Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex
- 1 January 2012
- journal article
- Published by Elsevier BV in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 80 (1), 67-75
- https://doi.org/10.1016/j.ejpb.2011.08.002
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Preparation and evaluation of celecoxib-loaded microcapsules with self-microemulsifying coreJournal of Microencapsulation, 2009
- Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusionEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Celecoxib-Cyclodextrin Systems: Characterization and Evaluation of In Vitro and In Vivo AdvantageDrug Development and Industrial Pharmacy, 2005
- Celecoxib Incorporated Chitosan Microspheres:In VitroandIn VivoEvaluationJournal of Drug Targeting, 2004
- Solubility enhancement of celecoxib using β-cyclodextrin inclusion complexesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Colon-specific drug delivery: new approaches and in vitro/in vivo evaluationInternational Journal of Pharmaceutics, 2002
- Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drugArthritis & Rheumatism, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Celecoxib for the treatment of pain and inflammation: the preclinical and clinical resultsJournal of Osteopathic Medicine, 1999
- Site-specific drug delivery and penetration enhancement in the gastrointestinal tractJournal of Controlled Release, 1995